Skip to main content
OpenTrials
Completed

NCT Number: NCT02711358

Indomethacin Use in Pain Relief During Intrauterine Device Insertion

The aim of the investigators study is to test the analgesic effect of rectal indomethacin during Intrauterine device insertion.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Family Planning

Age range

20 year–49 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 4

Primary location

Ahmed Abbas

Assiut, Cairo Governorate, 002, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Women not taken analgesics or anxiolytics in the 24 hours prior insertion
  • Women not taken misoprostol prior to intrauterine device insertion
  • Women who will accept to participate in the study

Exclusion criteria

  • Any contraindication to intrauterine device placement

Treatment and study plan

indomethacin suppositories

Drug

The patients will be instructed to self-administer a single rectal dose of 50 mg indomethacin 30 min before the scheduled time of the procedure

Placebo

Drug

The patient swill be instructed to self-administer a single rectal dose of placebo 30 min before the scheduled time of the procedure

Primary outcomes

  1. Mean pain score during IUD insertion

    Time frame: intraoperative

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Official study title

Rectal Indomethacin Use in Pain Relief During Intrauterine Device Insertion: A Randomized Controlled Trial

Acronym: INDO-IUD

Important dates

Study start
2016
Primary completion
2016
Study completion
2016
First posted
Mar 17, 2016
Registry last updated
Nov 29, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.